Judy H. Chang
For a commercial technology transfer, the ultimate measure of success is regulatory approval of the transferred process at the new site.
Raymond Chen, Dan Bowles, Fredrick Antosz, Yanqiao Xiang, Shelly Li, Mark Barrila, Michael Coutant
The amount of time required to successfully develop a new drug candidate from discovery to commercialization is estimated to be 12-15 years and the associated cost to be approximately $1 Billion dollars [1].
Ana Maria Valderrama , M.D., Eduardo F. Motti, M.D.
Latin American (LA) countries operate increasingly in accordance
with international standards and guidelines. This has been a major
driver for increasing interest and placement of clinical studies
in the region.
William R. Sutterlin, Ph.D
Passive processes for thermal energy storage have received a lot of
attention in the past 25 years. These passive thermal energy storage
materials can typically be divided into two parts, specific and latent.
This paper will primarily focus on the concept of latent heat.
John P. Devine, DABT, David Buckley, Ph.D., Kammie Settle, Eita Kitayama, MSc., Leigh Berryman, Michael Kim, Nancy L. DiGiulio, Nancy Gillett, DVM, PhD, DACVP
From my perspective, it appears many companies are paying
more attention to value or getting the most service for invested
dollars
Cristina Manolescu, Scott Pennino, Daniel L. Norwood, Ph.D.
A significant body of scientific and regulatory knowledge has been
accumulated over the past two decades regarding “leachables”
in various drug product types and dosage forms.
Drew Natenshon
Managing research and providing the right structures to allow
innovation to flourish is not trivial.
Tina M. Sturgill
Why should pharmaceutical companies consider outsourcing laboratory
services, particularly in today’s uncertain economic times?